Donald J. Trump
http://www.trumponline.com/Donald Trump is a real estate developer, American business executive, and entrepreneur. He is the CEO of Trump Organization, a real estate development company based in New York.
Trump graduated from the Wharton School of Business at the University of Pennsylvania in 1968 with a BS in economics and a concentration in finance. He then joined his father's company, the Trump Organization, where he developed and revitalized properties in Manhattan.
Trump found additional success as a TV star on the hit show The Apprentice, where he coined the term 'You're Fired!'.
In 2016, Trump ran for President of the U.S. as a Republican. After topping a large field of 16 other Republicans he was selected as the nominees. He then faced Democrat Hillary Clinton and beat her in a contentious race to become President of the U.S. Trump's platform of 'Make America Great Again' and 'Drain the Swamp' resonated with white, working class citizens.
View Older Stories
-
NIH tests therapies to help cut hospital stays for COVID-19 patients
-
Pfizer says earliest U.S. filing for COVID-19 vaccine would be late November
-
U.S. pauses Eli Lilly trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
-
European shares tumble on J&J vaccine worries, banks slide
-
Q&A: Where are we in the COVID-19 vaccine race?
-
Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sources
-
Most Americans to be vaccinated for COVID-19 by July, CDC chief expects
-
J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers
-
Pfizer vaccine trial bets on early win against coronavirus, documents show
-
U.S., European COVID-19 vaccine developers pledge to uphold testing rigour
-
COVID-19 vaccine diplomacy: Mexico courts allies across ideological spectrum
-
Exclusive: Fauci says rushing out a vaccine could jeopardize testing of others
-
Vaccine makers including Moderna must hit U.S. timing goals for full payments
-
Exclusive: U.S. recruits scientists abroad for COVID-19 vaccine trials, pledges access to supply
-
Coronavirus test ramp-up to help Abbott weather 'toughest quarter'
-
Wall Street jumps as hopes for easing lockdown offset earnings worry
-
Wall Street rallies, led by healthcare jump
-
German coronavirus vaccine developer CureVac denies any U.S. bid
-
Germany tries to halt U.S. interest in firm working on coronavirus vaccine
-
Americans rush to stock up on essentials, retailers scramble to keep up
-
Johnson & Johnson Names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors
-
Stocks pause on unsettled trade deal; earnings eyed
-
Wall Street slips as financials drag, trade outlook clouds
-
Wall Street slips as bank earnings, Trump trade comments weigh
-
Exclusive: India, U.S. closing in on package deal to remove trade irritants
-
Trump administration proposes production quota cuts for six opioids
-
FDA names drugmakers potentially acting to delay cheap generics
-
U.S. seeks time to consider joining opioid litigation
-
S&P 500 caps off strongest week in five years
-
New York City sues drug companies over opioid epidemic
-
Investor group presses U.S. drug companies on opioid controls
-
Dow pierces 23,000 but ends below milestone
-
Wall Street ticks higher to record close; eyes on earnings, Fed
-
President Trump Announces End of Strategic & Policy Forum and Manufacturing Council on Twitter
-
J&J sees sales growth in near-term; raises 2017 profit forecast
-
America’s hungriest wind and solar power users: big companies
-
Cross-border M&A between U.S. and European firms at 10 year high
-
Goldman Sachs, J&J pull Wall Street lower
-
U.S. trade group hacked with Chinese software ahead of Xi summit
-
Trump helps make cross-border M&A great again
-
Wall Street ends up slightly; energy shares rebound
-
'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks
-
With businesses split on U.S. border tax, wider reform looks shaky
-
Merck reveals seven years of its U.S. drug price increase history
-
European shares get M&A boost, climb to one-year high
-
Stocks near record high, dollar up on optimism, earnings
-
2016 Industry Pressures Drive Mixed Healthcare Investor Sentiment in 4th Quarter
-
Johnson & Johnson plans more price transparency; eyes U.S. tax, healthcare changes
-
Wall Street ends choppy session higher, health lags on Trump comments
-
Johnson & Johnson shares could rally about 20 percent: Barron's